BRIEF-Ascletis Pharma Says ASC47 Showed Greater Efficacy With Tirzepatide

Reuters
Aug 13
BRIEF-<a href="https://laohu8.com/S/ASCLF">Ascletis Pharma</a> Says ASC47 Showed Greater Efficacy With Tirzepatide

Aug 13 (Reuters) - Ascletis Pharma Inc 1672.HK:

  • ANNOUNCES ASC47 SHOWS GREATER EFFICACY WITH TIRZEPATIDE

  • ASC47 AND TIRZEPATIDE COMBINATION SHOWS 87% GREATER WEIGHT REDUCTION

Further company coverage: 1672.HK

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10